When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis made use of the EMR to obtain orders against some generic manufacturers who had already launched Gleevec in India. [173] Novartis set the price of Gleevec at US$2666 per patient per month; generic companies were selling their versions at US$177 to 266 per patient per month. [174]

  3. List of companies listed on the National Stock Exchange of India

    en.wikipedia.org/wiki/List_of_companies_listed...

    This is a list of companies listed on the National Stock Exchange of India (NSE). Contents !–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z !–9 Symbol ...

  4. Novartis v. Union of India & Others - Wikipedia

    en.wikipedia.org/wiki/Novartis_v._Union_of_India...

    Novartis made use of the EMR to obtain orders against some generic manufacturers who had already launched Gleevec in India. Novartis set the price of Gleevec at USD 2666 per patient per month; generic companies were selling their versions at USD 177 to 266 per patient per month.

  5. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share). 26 2006 Johnson & Johnson: Guidant: 24.2 37

  6. Novartis may divest generic unit Sandoz as price ... - AOL

    www.aol.com/news/novartis-more-bullish-cosentyx...

    (Reuters) -Novartis has raised the prospect of divesting its generic drugs unit Sandoz after years of revamping the business, as price pressures mount in the off-patent drug sector. "Novartis has ...

  7. Novartis begins tender offer for cancer-focused MorphoSys - AOL

    www.aol.com/news/novartis-begins-tender-offer...

    The Swiss drugmaker said its cash offer price of 68 euros per MorphoSys share corresponds to a premium of 142% on the volume-weighted aver Novartis begins tender offer for cancer-focused MorphoSys ...

  8. Novartis sues US government over Medicare drug price ... - AOL

    www.aol.com/news/novartis-sues-us-government...

    Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine ...

  9. List of largest companies in India - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_companies...

    Maruti Suzuki India: Automotive 120,293 33% 8,211 New Delhi 25 Nayara Energy: Oil and gas 116,240 19% 9,426 Mumbai 26 Steel Authority of India: Iron and steel 111,501 6% 2,177 New Delhi Yes 27 Canara Bank: Banking 111,210 18% 11,255 Bangalore Yes 28 Bank of Baroda: Banking 110,778 26% 14,905 Vadodara: Yes 29 Axis Bank: Banking 106,155 23% ...